So the first type is to base a retinal vein occlusion based on the parts of the retina that it's involving. So you can have something called a central retinal vein occlusion, and that's where you ...

Central retinal vein occlusion (CRVO) is a common retinal vascular disorder with potential risk of blindness. CRVO can be categorized into two distinct entities – non-ischemic and ischemic.

Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...

Considering taking supplements to treat retinal vein occlusion? Below is a list of common natural remedies used to treat or reduce the symptoms of retinal vein occlusion. Follow the links to read ...

They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...

These quiz questions about retinal vein occlusion (RVO) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

Eylea HD results were consistent across patients with branch RVOs and those with central retinal or hemiretinal vein occlusions. In the past three months, shares of REGN have plunged 35.7% compare ...

Intact external limiting membrane in spectral domain-optical coherence tomography imaging is ... in patients with ME secondary to central retinal vein occlusion. The dilemma still holds regarding ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...